BRMS1 and central nervous system cancer: An interesting future experiment to further determine the expression patterns in different cell types of glioma tissue would be double fluorescence staining with BRMS1 and cell-type-specific markers, such as IDH1R132H, NeuN, GFAP, or CD68.